Strong Results. True Simplicity. Is Omnipod® 5 Changing The Trade-Off?
15:00 – 15:30 Strong Results. True Simplicity. Is Omnipod® 5 Changing The Trade-Off? Emma Wilmot (GBR)Paolo Di Bartolo (ITA) Thursday, 01 October 2026 15:00 –
15:00 – 15:30 Strong Results. True Simplicity. Is Omnipod® 5 Changing The Trade-Off? Emma Wilmot (GBR)Paolo Di Bartolo (ITA) Thursday, 01 October 2026 15:00 –
Chair: Luigi Laviola (ITA) 15:00 – 15:30 Exploring the power of predictive CGM: Insights on performance, psychology, and the perspective of people living with diabetes
Chairs: Alice Cheng (CAN), Peter Rossing (DNK) 12:15 – 12:45 Case 1: Early simultaneous combination use Case 2: Rapid sequential GDMT implementation Alice Cheng (CAN) Peter
Chair: W. Timothy Garvey (USA) 12:15 – 12:17 Welcome and introduction W. Timothy Garvey (USA) 12:17 – 12:38 Amylin in action: from mechanisms to meaningful
Chair: Chantal Mathieu (BEL) 17:45 – 17:50 Welcome and introduction Chantal Mathieu (BEL) 17:50 – 18:00 From guideline recommendations to clinical reality: Barriers to achieving
Chair: Carel Le Roux (IRL) 17:45 – 17:50 Opening perspectives: framing the amylin story Carel Le Roux (IRL) 17:50 – 18:05 Amylin biology in action:
Chair: Gianluca Perseghin (ITA) 17:45 – 17:47 Welcome & Objectives Gianluca Perseghin (ITA) 17:47 – 17:57 MASH in Diabetes Care: Who to Treat, Why Now?
Chair: Thozhukat Sathyapalan (GBR) 17:45 – 18:15 Muscle Health in Diabetes: A New Lever to Improve Glycemic Control and Patient Outcomes Maarten Soeters (NLD)Francesco Landi
Chair: Lorenzo Piemonti (ITA) 16:00 – 16:02 Introduction Lorenzo Piemonti (ITA) 16:02 – 16:07 Unmet needs and challenges for people living with T1D Lorenzo Piemonti
16:00 – 16:05 Opening — the unhealthy cost of waiting Arya Sharma (DEU) 16:05 – 16:10 Obesity as a chronic progressive disease Arya Sharma (DEU)